$3.69
0.092.50%
At close: -
$3.25
-0.44-11.92%
After Hours: Jan 16, 5:24 PM EDT
Comments
Loading...
Lantern Pharma (NASDAQ:LTRN) Stock, Earnings Estimates, EPS, And Revenue
Lantern Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 17
EPS Estimate
$-0.510
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Lantern Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Lantern Pharma (LTRN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.42 | $-0.56 | 25.0 % |
| Q2 | 2024-08-08 | $-0.46 | $-0.55 | 16.4 % |
| Q1 | 2024-05-09 | $-0.51 | $-0.43 | -18.6 % |
| Q4 | 2024-03-18 | $-0.39 | $-0.40 | 2.50 % |
Lantern Pharma (LTRN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Lantern Pharma (NASDAQ:LTRN) reporting earnings?
Lantern Pharma (LTRN) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Lantern Pharma (NASDAQ:LTRN)?
The Actual EPS was $-0.42, which beat the estimate of $-0.56.
What were Lantern Pharma’s (NASDAQ:LTRN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.